Literature DB >> 14743501

Expression of acyl-CoA synthetase 5 reflects the state of villus architecture in human small intestine.

Nikolaus Gassler1, Jürgen Kopitz, Arman Tehrani, Birgit Ottenwälder, Martina Schnölzer, Jürgen Kartenbeck, Stefan Lyer, Frank Autschbach, Annemarie Poustka, Herwart F Otto, Jan Mollenhauer.   

Abstract

Several disorders of the small intestine are associated with disturbances in villus architecture. Thus, an understanding of the molecular mechanisms associated with the differentiation of villi represents an important step in the improvement of the understanding of small intestinal pathology. Screening of antibodies from a hybridoma library led to the identification of an acyl-CoA synthetase 5-specific monoclonal antibody. Protein synthesis, mRNA expression, and the enzyme activity of acyl-CoA synthetase 5 were studied by several methods in human small intestinal tissues with Crohn's disease or coeliac disease, respectively. Acyl-CoA synthetase 5 mRNA and protein levels were substantially reduced in injured small intestinal mucosa. Moreover, impaired synthesis of the acyl-CoA synthetase 5 protein was reflected by a decrease in intramucosal enzyme activity. Subtle changes of the acyl-CoA synthetase 5 pattern correlate with conversion of intestinal epithelial cells to a gastric phenotype. These results suggest that deranged acyl-CoA synthetase 5 expression, synthesis, and activity are closely related to the state of villus architecture and epithelial homeostasis in human small intestine. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14743501     DOI: 10.1002/path.1504

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Molecular characterisation of non-absorptive and absorptive enterocytes in human small intestine.

Authors:  N Gassler; D Newrzella; C Böhm; S Lyer; L Li; O Sorgenfrei; L van Laer; B Sido; J Mollenhauer; A Poustka; P Schirmacher; N Gretz
Journal:  Gut       Date:  2006-03-23       Impact factor: 23.059

2.  Coeliac disease is associated with impaired expression of acyl-CoA-synthetase 5.

Authors:  N Obermüller; M Keith; J Kopitz; F Autschbach; P Schirmacher; N Gassler
Journal:  Int J Colorectal Dis       Date:  2005-04-05       Impact factor: 2.571

3.  Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.

Authors:  Elke Kaemmerer; Anne Peuscher; Andrea Reinartz; Christian Liedtke; Ralf Weiskirchen; Jürgen Kopitz; Nikolaus Gassler
Journal:  World J Gastroenterol       Date:  2011-11-28       Impact factor: 5.742

4.  Gene expression profiling in sinonasal adenocarcinoma.

Authors:  Dominique Tripodi; Sylvia Quéméner; Karine Renaudin; Christophe Ferron; Olivier Malard; Isabelle Guisle-Marsollier; Véronique Sébille-Rivain; Christian Verger; Christian Géraut; Catherine Gratas-Rabbia-Ré
Journal:  BMC Med Genomics       Date:  2009-11-10       Impact factor: 3.063

5.  Predicting disease risk using bootstrap ranking and classification algorithms.

Authors:  Ohad Manor; Eran Segal
Journal:  PLoS Comput Biol       Date:  2013-08-22       Impact factor: 4.475

6.  High ACSL5 transcript levels associate with systemic lupus erythematosus and apoptosis in Jurkat T lymphocytes and peripheral blood cells.

Authors:  Antonio Catalá-Rabasa; Dorothy Ndagire; Jose Mario Sabio; Maria Fedetz; Fuencisla Matesanz; Antonio Alcina
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

7.  Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.

Authors:  Wei-Ching Chen; Chih-Yang Wang; Yu-Hsuan Hung; Tzu-Yang Weng; Meng-Chi Yen; Ming-Derg Lai
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

8.  A large deletion on CFA28 omitting ACSL5 gene is associated with intestinal lipid malabsorption in the Australian Kelpie dog breed.

Authors:  Mitchell J O'Brien; Niek J Beijerink; Mandy Sansom; Sarah W Thornton; Tracy Chew; Claire M Wade
Journal:  Sci Rep       Date:  2020-10-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.